Anixa Biosciences, Inc. (ANIX) — Financial statements
Income statement, balance sheet, and cash flow for Anixa Biosciences, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00 | 0.00↓100.0% | 0.21 | 0.00↓100.0% | 0.51 | |
| Cost of Revenue | 0.04 | 0.00↓100.0% | 0.16 | 0.00↓100.0% | 0.39 | |
| Gross Profit | -0.04 | 0.00↓100.0% | 0.05 | 0.00↓100.0% | 0.13 | |
| Operating Expenses | ||||||
| R&D Expenses | 5↓20.7% | 6↑34.1% | 5↓28.9% | 7↑8.3% | 6 | |
| General & Administrative Expenses | 7↓10.8% | 7↑18.2% | 6↓12.3% | 7↑1.4% | 7 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 7↓10.8% | 7↑18.2% | 6↓12.3% | 7↑1.4% | 7 | |
| Other Expenses | -0.04 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 12↓15.7% | 14↑25.1% | 11↓20.3% | 14↑4.6% | 13 | |
| Total Costs & Expenses | 12↓15.4% | 14↑23.3% | 11↓19.1% | 14↑1.7% | 14 | |
| Operating Results | ||||||
| Operating Income | -12↑15.4% | -14↓25.6% | -11↑20.6% | -14↓5.6% | -13 | |
| Depreciation & Amortization | 0.04↓2.7% | 0.04↓19.6% | 0.05↑9.5% | 0.04↓29.8% | 0.06 | |
| EBITDA | -12↑7.6% | -13↓15.5% | -11↑20.1% | -14↓5.0% | -13 | |
| EBIT | -12↑7.9% | -13↓15.3% | -11↑20.0% | -14↓4.8% | -13 | |
| Interest & Other Income | ||||||
| Net Interest Income | 0.67↓40.6% | 1↑4.8% | 1 | 0.00↓100.0% | 0.00 | |
| Interest Income | 0.67↓40.6% | 1↑4.8% | 1↑939.4% | 0.10↑4378.9% | 0.00 | |
| Interest Expense | 0.00 | 0.00 | 0.00↓100.0% | 0.10↑32198.1% | 0.00 | |
| Non-Operating Income | 0.00↑100.0% | -1 | 0.00↑100.0% | -0.10↓33866.2% | 0.00 | |
| Other Income / Expenses | 0.67↓40.6% | 1↑4.8% | 1↑939.4% | 0.10↑1238.7% | 0.01 | |
| Income Before Tax | -11↑13.2% | -13↓27.9% | -10↑27.9% | -14↓4.9% | -13 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -11↑13.2% | -13↓27.9% | -10↑27.9% | -14↓4.9% | -13 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -11↑13.0% | -13↓28.0% | -10↑27.8% | -14↓5.0% | -13 | |
| Bottom-Line Net Income | -11↑13.0% | -13↓28.0% | -10↑27.8% | -14↓4.9% | -13 | |
| EPS (Basic) | -0.34↑12.8% | -0.39↓21.9% | -0.32↑28.9% | -0.45↑0.0% | -0.45 | |
| EPS (Diluted) | -0.34↑12.8% | -0.39↓21.9% | -0.32↑28.9% | -0.45↑0.0% | -0.45 | |
| Weighted Average Shares | 32↑1.7% | 32↑3.0% | 31↑2.0% | 30↑6.3% | 29 | |
| Weighted Average Diluted Shares | 32↑1.7% | 32↑3.0% | 31↑2.0% | 30↑6.3% | 29 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.